Athira Pharma
Signal active
Organization
Contact Information
Overview
Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders.
Athira is derived from the word Athir, the energy that reaches everyone. It captures its mission to develop therapies that can reach and positively impact everyone.
About
Industries
Biotechnology, Pharmaceutical, Therapeutics
Founded
2011
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Athira Pharma headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $22.4B in funding across 96 round(s). With a team of 51-100 employees, Athira Pharma is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Athira Pharma, raised $3.5M. Discover more about their projects, partnerships, and impact on our platform.
Employees
Funding Rounds
Funding rounds
8
Investors
0
Lead Investors
0
Total Funding Amount
$233.6M
Details
3
Athira Pharma has raised a total of $233.6M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Early Stage Venture | 15.2M | ||
| 2020 | Early Stage Venture | 85.0M | ||
| 2016 | Early Stage Venture | 10.0M |
Investors
Athira Pharma is funded by 32 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Athira Pharma | - | FUNDING ROUND - Athira Pharma | 1.4M |
| Dolby Family Ventures | - | FUNDING ROUND - Dolby Family Ventures | 1.4M |
| Athira Pharma | - | FUNDING ROUND - Athira Pharma | 10.0M |
| Dolby Family Ventures | - | FUNDING ROUND - Dolby Family Ventures | 10.0M |
Recent Activity
There is no recent news or activity for this profile.